Soleno Therapeutics, Inc. (SLNO)
NASDAQ·Healthcare·Biotechnology
$52.77
+0.04%
Mkt Cap $2.73B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $88.75M | $91.73M | +3.36% | $0.64 | $0.80 | +25.00% | — | — |
| Q4 2025 Nov 4, 2025 | $88.55M | $66.02M | -25.44% | $0.06 | $0.47 | +717.39% | — | — |
| Q3 2025 Aug 6, 2025 | $39.35M | $32.66M | -17.01% | -$0.53 | -$0.09 | +83.02% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$1.14 | -$0.95 | +16.67% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.63 | -$1.27 | -101.59% | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | -$0.61 | -$1.83 | -200.00% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.63 | -$0.57 | +9.52% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.30 | -$0.59 | -96.67% | — | — |
| Q1 2024 Mar 6, 2024 | — | $3.45M | — | -$0.31 | -$0.33 | -6.45% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.62 | -$0.95 | -53.23% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.70 | -$0.81 | -15.71% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.71 | -$0.88 | -23.94% | — | — |
| Q1 2023 Mar 21, 2023 | — | — | — | -$0.76 | -$0.58 | +23.68% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$1.05 | -$0.76 | +27.62% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$1.05 | -$0.90 | +14.29% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$1.35 | -$1.05 | +22.22% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$1.20 | -$1.20 | +0.00% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$1.65 | -$1.50 | +9.09% | — | — |
| Q3 2021 Jul 28, 2021 | — | — | — | -$1.20 | -$2.10 | -75.00% | — | — |
| Q2 2021 May 5, 2021 | — | — | — | -$0.60 | -$1.65 | -175.00% | — | — |